High Airway‐To‐Vessel Volume Ratio and Visual Bronchiectasis Are Associated With Exacerbations in <scp>COPD</scp>
High AVR was associated with a shorter time to first exacerbation, complementary to mReiff score and PA/Ao, suggesting that AVR is a novel CT-derived predictor of exacerbation in COPD.
Authors
- Susumu Satô (ORCID: https://orcid.org/0000-0002-9626-1090)
- Yuichi Kojima (ORCID: https://orcid.org/0000-0001-8337-884X)
- Shigeo Muro (ORCID: https://orcid.org/0000-0001-7452-9191)
- Ichizo Tsujino (ORCID: https://orcid.org/0000-0002-0196-9572)
- Michiko Sato (ORCID: https://orcid.org/0000-0002-3998-3820)
- Toyohiro Hirai (ORCID: https://orcid.org/0000-0002-7431-9044)
- Naoya Tanabe (ORCID: https://orcid.org/0000-0002-7481-0212)
- Kazufumi Okada (ORCID: https://orcid.org/0000-0002-6537-376X)
- Akira Oguma (ORCID: https://orcid.org/0000-0003-3732-8483)
- Nozomu Takei (ORCID: https://orcid.org/0000-0002-5091-3065)
- Kaoruko Shimizu (ORCID: https://orcid.org/0000-0002-2785-4634)
- Houman Goudarzi (ORCID: https://orcid.org/0000-0003-1145-8917)
- Hironi Makita (ORCID: https://orcid.org/0000-0002-4208-8982)
- Masaharu Nishimura (ORCID: https://orcid.org/0000-0002-6456-4361)
- Nobuyasu Wakazono (ORCID: https://orcid.org/0000-0003-3865-8660)
- Hirokazu Kimura (ORCID: https://orcid.org/0000-0002-9835-6659)
- Yuki Abe (ORCID: https://orcid.org/0009-0001-7911-8102)
- Hiroki Nishimura (ORCID: https://orcid.org/0009-0001-2832-4934)
- Satoshi Konno
- Munehiro Matsumoto
- Takeshi Hattori
- M. Wakazono
- Ayako Igarashi‐Sugimoto (ORCID: https://orcid.org/0000-0002-0143-6717)
Institutions
- Hokkaido University (JP)
- Kyoto University (JP)
- National Hospital Organization Hokkaido Medical Center (JP)
- Hokkaido University Hospital (JP)
- Hokkaido Institute of Public Health (JP)
- Nara Medical University (JP)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Respirology
- Published
- 2025-08-31
- DOI
- https://doi.org/10.1111/resp.70114
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Pfizer
- Boehringer Ingelheim Japan
- Ministry of Health, Labour and Welfare
- Hokkaido University
- Pfizer Japan